{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:21:03Z","timestamp":1789647663758,"version":"4.0.0"},"reference-count":45,"publisher":"Index Copernicus","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol Przegl Chir"],"published-print":{"date-parts":[[2022,8,12]]},"abstract":"<jats:p>&lt;b&gt;Introduction:&lt;\/b&gt; The anatomical location of the popliteal artery is one of the greatest challenges for percutaneous interventions. The biomechanical attributes of the vessel lead to higher rates of restenosis, stent fracture, and occlusion. Some surgeons consider the popliteal artery as a \u201cno stenting zone\u201d. Many specialists favor percutaneous transluminal angioplasty to be the first line of endovascular treatment in the popliteal artery with bail-out stent implantation if the results are suboptimal. The Supera peripheral stent system is a novel stent that has been manufactured with a high degree of flexibility and supposedly might be appropriate for implantation in the popliteal artery. &lt;\/br&gt;&lt;\/br&gt; &lt;b&gt;Aim:&lt;\/b&gt; Evaluation of the performance of Supera stent in isolated popliteal artery disease in comparison to other methods of treatment. &lt;\/br&gt;&lt;\/br&gt; &lt;b&gt;Methods:&lt;\/b&gt; As many as 92 articles were found in the databases and after full-text review, 4 studies matched the inclusion criteria and were evaluated. &lt;\/br&gt;&lt;\/br&gt; &lt;b&gt;Results:&lt;\/b&gt; Primary patency rates of Supera implantation in an isolated popliteal artery at 12 months ranged from 68% to 90%. In all four studies, no stent fractures were observed. Only one study provided longer follow-up than 12 months and evaluated the performance of the Supera stent 36 months after implantation. &lt;\/br&gt;&lt;\/br&gt; &lt;b&gt;Conclusion:&lt;\/b&gt; In conclusion, mentioned studies show promising and superior to other stent patency rates of the Supera stent regarding popliteal artery lesions. What is more, no stent fracture is promising regarding longer follow-up. However, more studies with longer follow-ups and direct comparison to other methods are required to fully evaluate Supera's performance in the popliteal artery.<\/jats:p>","DOI":"10.5604\/01.3001.0015.9578","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T08:06:12Z","timestamp":1666598772000},"page":"47-53","source":"Crossref","is-referenced-by-count":7,"title":["Supera stent implantation for the treatment of isolated popliteal artery disease \u2013 systematic review and evaluation of current endovascular strategies"],"prefix":"10.5604","volume":"95","author":[{"given":"Szymon","family":"Salamaga","sequence":"first","affiliation":[{"name":"Department of General and Vascular Surgery, Medical University of Karol Marcinkowski in Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"St\u0119pak","sequence":"additional","affiliation":[{"name":"Department of General and Vascular Surgery, Medical University of Karol Marcinkowski in Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Krasi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of General and Vascular Surgery, Medical University of Karol Marcinkowski in Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3689","reference":[{"key":"230554r1","doi-asserted-by":"crossref","unstructured":"Fowkes F.G.R., Rudan D., Rudan I. et al.: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (London, England), 2013; 382: 1329\u2013 1340. https:\/\/doi.org\/10.1016\/S0140-6736(13)61249-0.","DOI":"10.1016\/S0140-6736(13)61249-0"},{"key":"230554r2","doi-asserted-by":"crossref","unstructured":"Marston W.A., Davies S.W., Armstrong B. et al.: Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascu- larization. J Vasc Surg, 2006; 44. https:\/\/doi.org\/10.1016\/J.JVS.2006.03.026.","DOI":"10.1016\/j.jvs.2006.03.026"},{"key":"230554r3","doi-asserted-by":"crossref","unstructured":"Ghanem M., Meyer F., Halloul Z.: Covering\/Overstenting of the left subclavian artery (LSA) in thoracic endovascular repair (TEVAR) to treat various thoracic\/thoracoabdominal aortic lesions: Is revascularization of the left arm a must?(A retrospective cohort study with 12 years of experience to describe the real-world situation of daily clinical practice and the literature review). Polish J Surg, 2022; 94: 1\u20135. https:\/\/doi.org\/10.5604\/01.3001.0015.7090.","DOI":"10.5604\/01.3001.0015.7090"},{"key":"230554r4","doi-asserted-by":"crossref","unstructured":"Wolf B., Czajkowska M., Dorobisz A.: Intraoperative Carotid Artery Injuries. Review of theliterature, analysis of the material of one centre. Polish J Surg, 2021; 94: 1\u20136. https:\/\/doi.org\/10.5604\/01.3001.0015.6102.","DOI":"10.5604\/01.3001.0015.6102"},{"key":"230554r5","doi-asserted-by":"crossref","unstructured":"Garg K., Kaszubski P.A., Moridzadeh R. et al.: Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia. J Vasc Surg, 2014; 59: 392\u2013399. https:\/\/doi.org\/10.1016\/J.JVS.2013.09.001.","DOI":"10.1016\/j.jvs.2013.09.001"},{"key":"230554r6","doi-asserted-by":"crossref","unstructured":"Stavroulakis K., Schwindt A., Torsello G. et al.: Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for isolated popliteal artery lesions. J Endovasc Ther, 2017; 24: 181\u2013188. https:\/\/doi.org\/10.1177\/1526602816683933.","DOI":"10.1177\/1526602816683933"},{"key":"230554r7","doi-asserted-by":"crossref","unstructured":"Garcia L.A., Rosenfield K.R., Metzger C.D. et al.: SUPERB Final 3-Year Outcomes Using Interwoven Nitinol Biomimetic Supera Stent n.d. Catheter Cardiovasc Interv. 2017; 89: 1259\u20131267. https:\/\/doi.org\/10.1002\/ccd.27058.","DOI":"10.1002\/ccd.27058"},{"key":"230554r8","doi-asserted-by":"crossref","unstructured":"Le\u00f3n L.R., Dieter R.S., Gadd C.L. et al.: Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery. J Vasc Surg, 2013; 57: 1014\u20131022. https:\/\/doi.org\/10.1016\/J.JVS.2012.10.093.","DOI":"10.1016\/j.jvs.2012.10.093"},{"key":"230554r9","doi-asserted-by":"crossref","unstructured":"Panico A., Jafferani A., Shah F., Dieter R.S.: Advances in peripheral arterial disease endovascular revascularization. Cardiol Clin, 2015; 33: 89\u201398. https:\/\/doi.org\/10.1016\/J.CCL.2014.09.002.","DOI":"10.1016\/j.ccl.2014.09.002"},{"key":"230554r10","doi-asserted-by":"crossref","unstructured":"Laird J.R.: Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther, 2006; 13(Suppl 2): II-30-II\u201340. https:\/\/doi.org\/10.1583\/05-1754.1.","DOI":"10.1177\/15266028060130S207"},{"key":"230554r11","doi-asserted-by":"crossref","unstructured":"Ansari F., Pack L.K., Brooks S.S., Morrison T.M.: Design considerations for studies of the biomechanical environment of the femoropopliteal arteries. J Vasc Surg, 2013; 58: 804\u2013813. https:\/\/doi.org\/10.1016\/J.JVS.2013.03.052.","DOI":"10.1016\/j.jvs.2013.03.052"},{"key":"230554r12","unstructured":"Current and evolving strategies for the treatment of atherosclerotic disease of the popliteal artery n.d. https:\/\/www.researchgate.net\/publication\/267814649_Current_and_evolving_strategies_for_the_treatment_of_atherosclerotic_disease_of_the_popliteal_artery [accessed November 19, 2021]."},{"key":"230554r13","doi-asserted-by":"crossref","unstructured":"Shurtleff E., Vanderhyde M., Fitzwater F. et al.: A novel unembalmed human cadaveric limb model for assessing conformational changes in self-expanding nitinol stents in the popliteal artery. Catheter Cardiovasc Interv, 2019; 93: 113\u2013119. https:\/\/doi.org\/10.1002\/CCD.27930.","DOI":"10.1002\/ccd.27930"},{"key":"230554r14","doi-asserted-by":"crossref","unstructured":"San Norberto E.M., Flota C.M., Fidalgo-Domingos L., Taylor J.H., Vaquero C.: Real-World Results of Supera Stent Implantation for Popliteal Artery Atherosclerotic Lesions: 3-Year Outcome. Ann Vasc Surg, 2020; 62: 397\u2013405. https:\/\/doi.org\/10.1016\/J.AVSG.2019.06.038.","DOI":"10.1016\/j.avsg.2019.06.038"},{"key":"230554r15","doi-asserted-by":"crossref","unstructured":"San Norberto E.M., Fuente R., Flota C.M., Taylor J.H., Vaquero C.: Impact of Implantation Defects on Intermediate Outcome of Supera Stent for Popliteal Artery Stenosis. Ann Vasc Surg, 2017; 41: 186\u2013195. https:\/\/doi.org\/10.1016\/J.AVSG.2016.09.021.","DOI":"10.1016\/j.avsg.2016.09.021"},{"key":"230554r16","doi-asserted-by":"crossref","unstructured":"Goltz J.P., Ritter C.O., Kellersmann R. et al.: Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther, 2012; 19: 450\u2013456. https:\/\/doi.org\/10.1583\/11-3591MR.1.","DOI":"10.1583\/11-3591MR.1"},{"key":"230554r17","doi-asserted-by":"crossref","unstructured":"Scheinert D., Werner M., Scheinert S. et al.: Treatment of Complex Atherosclerotic Popliteal Artery Disease With a New Self-Expanding Interwoven Nitinol Stent: 12-Month Results of the Leipzig SUPERA Popliteal Artery Stent Registry. JACC Cardiovasc Interv, 2013; 6: 65\u201371. https:\/\/doi.org\/10.1016\/J.JCIN.2012.09.011.","DOI":"10.1016\/j.jcin.2012.09.011"},{"key":"230554r18","unstructured":"PMA P120020: FDA Summary of Safety and Effectiveness Data Summary of Safety and Effectiveness Data (SSED) n.d."},{"key":"230554r19","doi-asserted-by":"crossref","unstructured":"Rastan A., McKinsey J.F., Garcia L.A. et al.: One-Year Outcomes Following Directional Atherectomy of Popliteal Artery Lesions: Subgroup Analysis of the Prospective, Multicenter DEFINITIVE LE Trial. J Endovasc Ther, 2018; 25: 100\u2013108. https:\/\/doi.org\/10.1177\/1526602817740133.","DOI":"10.1177\/1526602817740133"},{"key":"230554r20","doi-asserted-by":"crossref","unstructured":"Semaan E., Hamburg N., Nasr W. et al.: Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg, 2010; 44: 25\u201331. https:\/\/doi.org\/10.1177\/1538574409345028.","DOI":"10.1177\/1538574409345028"},{"key":"230554r21","doi-asserted-by":"crossref","unstructured":"Rastan A., Krankenberg H., Baumgartner I. et al.: Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation, 2013; 127: 2535\u20132541. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001849.","DOI":"10.1161\/CIRCULATIONAHA.113.001849"},{"key":"230554r22","doi-asserted-by":"crossref","unstructured":"Jahnke T., Mueller-Huelsbeck S., Charalambous N. et al.: Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol, 2010; 21: 186\u2013194. https:\/\/doi.org\/10.1016\/J.JVIR.2009.10.021.","DOI":"10.1016\/j.jvir.2009.10.021"},{"key":"230554r23","doi-asserted-by":"crossref","unstructured":"Laird J., Jaff M.R., Biamino G. et al.: Cryoplasty for the treatment of femoropopliteal arterial disease: Results of a prospective, multicenter registry. J Vasc Interv Radiol, 2005; 16: 1067\u20131073. https:\/\/doi.org\/10.1097\/01.RVI.0000167866.86201.4E.","DOI":"10.1097\/01.RVI.0000167866.86201.4E"},{"key":"230554r24","doi-asserted-by":"crossref","unstructured":"Cioppa A., Stabile E., Popusoi G. et al.: Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revasc Med, 2012; 13: 219\u2013223. https:\/\/doi.org\/10.1016\/J.CARREV.2012.04.007.","DOI":"10.1016\/j.carrev.2012.04.007"},{"key":"230554r25","doi-asserted-by":"crossref","unstructured":"Stavroulakis K., Bisdas T., Torsello G., Stachmann A., Schwindt A.: Combined Directional Atherectomy and Drug-Eluting Balloon Angioplasty for Isolated Popliteal Artery Lesions in Patients With Peripheral Artery Disease. J Endovasc Ther, 2015; 22: 847\u2013852. https:\/\/doi.org\/10.1177\/1526602815608194.","DOI":"10.1177\/1526602815608194"},{"key":"230554r26","doi-asserted-by":"crossref","unstructured":"Werk M., Langner S., Reinkensmeier B. et al.: Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation, 2008; 118: 1358\u20131365. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.735985.","DOI":"10.1161\/CIRCULATIONAHA.107.735985"},{"key":"230554r27","doi-asserted-by":"crossref","unstructured":"Tepe G., Zeller T., Albrecht T. et al.: Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg., 2009; 358: 689\u2013699. https:\/\/doi.org\/10.1056\/NEJMOA0706356.","DOI":"10.1056\/NEJMoa0706356"},{"key":"230554r28","doi-asserted-by":"crossref","unstructured":"Conway A.M., Qato K., Bottalico D. et al.: Occluded Superficial Femoral and Popliteal Artery Stents Can Have a Negative Impact on Bypass Target. J Endovasc Ther, 2015; 22: 868\u2013873. https:\/\/doi.org\/10.1177\/1526602815607187.","DOI":"10.1177\/1526602815607187"},{"key":"230554r29","doi-asserted-by":"crossref","unstructured":"Davies M.G.: Three-year outcomes of the RESILIENT trial: are they enough to support a primary stenting policy? J Endovasc Ther, 2012; 19: 10\u201311. https:\/\/doi.org\/10.1583\/11-3627C.1.","DOI":"10.1583\/11-3627C.1"},{"key":"230554r30","doi-asserted-by":"crossref","unstructured":"Lammer J., Zeller T., Hausegger K.A. et al.: Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol, 2013; 62: 1320\u20131327. https:\/\/doi.org\/10.1016\/J.JACC.2013.05.079.","DOI":"10.1186\/ISRCTN48164244"},{"key":"230554r31","doi-asserted-by":"crossref","unstructured":"Saxon R.R., Chervu A., Jones P.A. et al.: Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol, 2013; 24: 165\u2013173. https:\/\/doi.org\/10.1016\/J.JVIR.2012.10.004.","DOI":"10.1016\/j.jvir.2012.10.004"},{"key":"230554r32","doi-asserted-by":"crossref","unstructured":"Dake M.D., Ansel G.M., Jaff M.R. et al.: Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation, 2016; 133: 1472\u20131483. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016900.","DOI":"10.1161\/CIRCULATIONAHA.115.016900"},{"key":"230554r33","doi-asserted-by":"crossref","unstructured":"Strecker E.P.K., Boos I.B.L., G\u00f6ttmann D., Vetter S., Haase W.: Popliteal Artery Stenting Using Flexible Tantalum Stents. Cardiovasc Interv Radiol, 2014; 24: 168\u2013175. https:\/\/doi.org\/10.1007\/S002700002526.","DOI":"10.1007\/s002700002526"},{"key":"230554r34","doi-asserted-by":"crossref","unstructured":"Rastan A., Krankenberg H., Baumgartner I. et al.: Stent placement vs. balloon angioplasty for popliteal artery treatment: Two-year results of a prospective, multicenter, randomized trial. J Endovasc Ther, 2015; 22: 22\u201327. https:\/\/doi.org\/10.1177\/1526602814564386.","DOI":"10.1177\/1526602814564386"},{"key":"230554r35","doi-asserted-by":"crossref","unstructured":"Parthipun A., Diamantopoulos A., Kitrou P. et al.: Use of a New Hybrid Heparin-Bonded Nitinol Ring Stent in the Popliteal Artery: Procedural and Mid-term Clinical and Anatomical Outcomes. Cardiovasc Intervent Radiol, 2015; 38: 846\u2013854. https:\/\/doi.org\/10.1007\/S00270-015-1113-4.","DOI":"10.1007\/s00270-015-1113-4"},{"key":"230554r36","unstructured":"Piorkowski M., Freitas B., Schmidt A. et al.: The use of the GORE TIGRIS Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months. J Cardiovasc Surg (Torino), 2013; 54: 447\u2013453."},{"key":"230554r37","doi-asserted-by":"crossref","unstructured":"Wright L.B., Matchett W.J., Cruz C.P. et al.: Popliteal artery disease: Diagnosis and treatment. Radiographics, 2004; 24: 467\u2013479. https:\/\/doi.org\/10.1148\/RG.242035117.","DOI":"10.1148\/rg.242035117"},{"key":"230554r38","doi-asserted-by":"crossref","unstructured":"Albers M., Battistella V.M., Romiti M., Eyer Rodrigues A.A., Bragan\u00e7a Pereira C.A.: Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg, 2003; 37: 1263\u20131269. https:\/\/doi.org\/10.1016\/S0741-5214(02)75332-9.","DOI":"10.1016\/S0741-5214(02)75332-9"},{"key":"230554r39","doi-asserted-by":"crossref","unstructured":"Albers M., Romiti M., Pereira C.A.B., Antonini M., Wulkan M.: Meta-analysis of allograft bypass grafting to infrapopliteal arteries. Eur J Vasc Endovasc Surg, 2004; 28: 462\u2013472. https:\/\/doi.org\/10.1016\/J.EJVS.2004.08.009.","DOI":"10.1016\/j.ejvs.2004.08.009"},{"key":"230554r40","doi-asserted-by":"crossref","unstructured":"Albers M., Romiti M., Brochado-Neto F.C., Pereira C.A.B.: Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg, 2005; 42: 449.e1-449.e8. https:\/\/doi.org\/10.1016\/J.JVS.2005.05.031.","DOI":"10.1016\/j.jvs.2005.05.031"},{"key":"230554r41","doi-asserted-by":"crossref","unstructured":"Bradbury A.W., Adam D.J., Bell J. et al.: Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgeryfirst or a balloon angioplasty-first revascularization strategy. J Vasc Surg, 2010; 51: 5S-17S. https:\/\/doi.org\/10.1016\/J.JVS.2010.01.073.","DOI":"10.1016\/j.jvs.2010.01.073"},{"key":"230554r42","doi-asserted-by":"crossref","unstructured":"Bradbury A.W., Adam D.J., Bell J. et al.: Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg, 2010; 51: 18S-31S. https:\/\/doi.org\/10.1016\/J.JVS.2010.01.074.","DOI":"10.1016\/j.jvs.2010.01.074"},{"key":"230554r43","doi-asserted-by":"crossref","unstructured":"Kim T.I., Sumpio B.E.: Management of Asymptomatic Popliteal Artery Aneurysms. Int J Angiol, 2019; 28: 5. https:\/\/doi.org\/10.1055\/S-0038-1676792.","DOI":"10.1055\/s-0038-1676792"},{"key":"230554r44","doi-asserted-by":"crossref","unstructured":"Huang Y., Gloviczki P., Noel A.A. et al.: Early complications and long-term outcome after open surgical treatment of popliteal artery aneurysms: is exclusion with saphenous vein bypass still the gold standard? J Vasc Surg, 2007;","DOI":"10.1016\/j.jvs.2006.12.011"},{"key":"230554r45","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/J.JVS.2006.12.011.45. Serrano Hernando F.J., Mart\u00ednez L\u00f3pez I., Hern\u00e1ndez Mateo M.M. et al.: Comparison of popliteal artery aneurysm therapies. J Vasc Surg, 2015; 61: 655\u2013661. https:\/\/doi.org\/10.1016\/J.JVS.2014.10.007.","DOI":"10.1016\/j.jvs.2014.10.007"}],"container-title":["Polish Journal of Surgery"],"original-title":[],"link":[{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0015.9578","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0015.9578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:30:15Z","timestamp":1700825415000},"score":1,"resource":{"primary":{"URL":"https:\/\/ppch.pl\/gicid\/01.3001.0015.9578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,7]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0015.9578","relation":{},"ISSN":["0032-373X","2299-2847"],"issn-type":[{"value":"0032-373X","type":"print"},{"value":"2299-2847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}